Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
India · Delayed Price · Currency is INR 134.23
+11.81 (9.65%)
Jun 11, 2026, 3:29 PM IST
NSE:LOTUSEYE Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,791 | 2,043 | 1,393 | 1,157 | 1,219 | 1,102 | |
Market Cap Growth | 83.35% | 46.62% | 20.38% | -5.03% | 10.57% | 29.27% |
Enterprise Value | 2,912 | 2,058 | 1,378 | 1,067 | 1,126 | 1,012 |
Last Close Price | 134.23 | 98.22 | 66.99 | 55.65 | 58.26 | 52.31 |
PE Ratio | 3472.00 | 2540.57 | 188.44 | 39.71 | 29.89 | 36.93 |
PS Ratio | 5.20 | 3.80 | 2.81 | 2.40 | 2.59 | 2.83 |
PB Ratio | 4.64 | 3.40 | 2.32 | 1.95 | 2.12 | 2.02 |
P/TBV Ratio | 4.66 | 3.41 | 2.33 | 1.95 | 2.12 | 2.02 |
P/FCF Ratio | - | - | - | 2871.75 | 94.46 | - |
P/OCF Ratio | 92.53 | 67.70 | 51.62 | 20.36 | 27.78 | 24.99 |
EV/Sales Ratio | 5.42 | 3.83 | 2.78 | 2.21 | 2.39 | 2.60 |
EV/EBITDA Ratio | 86.07 | 60.84 | 49.19 | 16.84 | 15.07 | 18.16 |
EV/EBIT Ratio | - | - | 159.08 | 32.92 | 22.39 | 27.77 |
EV/FCF Ratio | - | - | - | 2648.02 | 87.31 | - |
Debt / Equity Ratio | 0.26 | 0.26 | 0.06 | 0.02 | 0.01 | 0.02 |
Debt / EBITDA Ratio | 4.68 | 4.68 | 0.89 | 0.16 | 0.08 | 0.20 |
Debt / FCF Ratio | - | - | - | 27.55 | 0.52 | - |
Net Debt / Equity Ratio | 0.20 | 0.20 | -0.01 | -0.10 | -0.13 | -0.14 |
Net Debt / EBITDA Ratio | 3.55 | 3.55 | -0.20 | -0.92 | -1.02 | -1.36 |
Net Debt / FCF Ratio | -1.20 | -1.20 | 0.26 | -144.40 | -5.94 | 27.63 |
Asset Turnover | 0.71 | 0.71 | 0.73 | 0.74 | 0.75 | 0.64 |
Inventory Turnover | 10.37 | 10.37 | 11.06 | 11.54 | 12.80 | 13.38 |
Quick Ratio | 0.54 | 0.54 | 0.71 | 1.29 | 1.83 | 1.64 |
Current Ratio | 1.22 | 1.22 | 1.56 | 2.21 | 2.83 | 2.24 |
Return on Equity (ROE) | 0.13% | 0.13% | 1.24% | 4.98% | 7.27% | 5.56% |
Return on Assets (ROA) | -0.30% | -0.30% | 0.80% | 3.12% | 5.04% | 3.77% |
Return on Invested Capital (ROIC) | -0.55% | -0.56% | 0.82% | 4.55% | 7.49% | 5.89% |
Return on Capital Employed (ROCE) | -0.50% | -0.50% | 1.40% | 5.40% | 8.70% | 6.50% |
Earnings Yield | 0.03% | 0.04% | 0.53% | 2.52% | 3.35% | 2.71% |
FCF Yield | -3.59% | -4.91% | -1.53% | 0.03% | 1.06% | -0.25% |
Dividend Yield | - | - | - | - | 0.86% | 0.96% |
Payout Ratio | 14.55% | 14.55% | 1.45% | 34.73% | 25.50% | 34.63% |
Buyback Yield / Dilution | 2.12% | 2.12% | 1.35% | -0.07% | -0.38% | 0.34% |
Total Shareholder Return | 2.12% | 2.12% | 1.35% | -0.07% | 0.48% | 1.29% |